Cost‐effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer

Abstract

SBRT was nearly always the most cost-effective treatment strategy for MO patients with stage I NSCLC. In contrast, for patients with CO disease, lobectomy was the most cost-effective option.